Para depositar en Docta Complutense, identifícate con tu correo @ucm.es en el SSO institucional: Haz clic en el desplegable de INICIO DE SESIÓN situado en la parte superior derecha de la pantalla. Introduce tu correo electrónico y tu contraseña de la UCM y haz clic en el botón MI CUENTA UCM, no autenticación con contraseña.
 

Enhanced susceptibility of galectin-1 deficient mice to experimental colitis

dc.contributor.authorFernández Pérez, Raquel
dc.contributor.authorLópez Santalla, Mercedes
dc.contributor.authorSánchez Domínguez, Rebeca
dc.contributor.authorAlberquilla, Omaira
dc.contributor.authorGutiérrez Cañas, Irene
dc.contributor.authorJuarranz Moratilla, Yasmina
dc.contributor.authorBueren, Juan A.
dc.contributor.authorGarin, Marina I.
dc.date.accessioned2024-07-12T17:24:40Z
dc.date.available2024-07-12T17:24:40Z
dc.date.issued2021-06-28
dc.descriptionEste trabajo fue subvencionado por el Instituto de Salud Carlos III y cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER)
dc.description.abstractGalectin-1 is a<jats:italic>β</jats:italic>-galactoside-binding lectin, ubiquitously expressed in stromal, epithelial, and different subsets of immune cells. Galectin-1 is the prototype member of the galectin family which shares specificity with<jats:italic>β</jats:italic>-galactoside containing proteins and lipids. Immunomodulatory functions have been ascribed to endogenous galectin-1 due to its induction of T cell apoptosis, inhibitory effects of neutrophils and T cell trafficking. Several studies have demonstrated that administration of recombinant galectin-1 suppressed experimental colitis by modulating adaptive immune responses altering the fate and phenotype of T cells. However, the role of endogenous galectin-1 in intestinal inflammation is poorly defined. In the present study, the well-characterized acute dextran sulfate sodium (DSS)-induced model of ulcerative colitis was used to study the function of endogenous galectin-1 during the development of intestinal inflammation. We found that galectin-1 deficient mice (<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice) displayed a more severe intestinal inflammation, characterized by significantly elevated clinical scores, than their wild type counterparts. The mechanisms underlying the enhanced inflammatory response in colitic<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice involved an altered Th17/Th1 profile of effector CD4<jats:sup>+</jats:sup>T cells. Furthermore, increased frequencies of Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells in colon lamina propria in<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice were found. Strikingly, the exacerbated intestinal inflammatory response observed in<jats:italic>Lgals1<jats:sup>−</jats:sup></jats:italic><jats:sup>/</jats:sup><jats:italic><jats:sup>−</jats:sup></jats:italic>mice was alleviated by adoptive transfer of wild type Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells at induction of colitis. Altogether, these data highlight the importance of endogenous galectin-1 as a novel determinant in regulating T cell reactivity during the development of intestinal inflammation.
dc.description.departmentDepto. de Biología Celular
dc.description.facultyFac. de Ciencias Biológicas
dc.description.fundingtypePagado por el autor
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades (España)
dc.description.sponsorshipEuropean Commission
dc.description.statuspub
dc.identifier.citationFernandez-Perez R, Lopez-Santalla M, Sánchez-Domínguez R, Alberquilla O, Gutiérrez-Cañas I, Juarranz Y, Bueren JA and Garin MI (2021) Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis. Front. Immunol. 12:687443.
dc.identifier.doi10.3389/fimmu.2021.687443
dc.identifier.essn1664-3224
dc.identifier.officialurlhttps://doi.org/10.3389/fimmu.2021.687443
dc.identifier.urihttps://hdl.handle.net/20.500.14352/106065
dc.journal.titleFrontiers in Immunology
dc.language.isoeng
dc.page.final13
dc.page.initial1
dc.publisherFrontiers Media
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00078/ES/MECANISMOS REGULADORES DE LA EXPRESION, SEÑALIZACION Y FUNCION DE LOS RECEPTORES VPAC PARA VALIDAR SU APLICACION CLINICA EN ENFERMEDADES INFLAMATORIAS%2FAUTOINMUNES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F00027/ES/EJE VIP%2FRECEPTORES COMO BIOMARCADOR EN ENFERMEDADES REUMATICAS Y SU IMPLICACION EN LA DESTRUCCION DE CARTILAGO Y HUESO/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RD16%2F0012%2F0008/ES/Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER)/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//PIE15%2F00048/ES/mRNA ENGINEERED MESENCHYMAL STROMAL CELLS: A NEW GENERATION OF CELL THERAPY FOR INFLAMMATORY DISEASES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F01161/ES/TERAPIA CELULAR CON CELULAS MADRE MESENQUIMALES PARA EL TRATAMIENTO DE LA ARTRITIS REUMATOIDE/
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu57.083
dc.subject.cdu615.37
dc.subject.cdu616.348-002
dc.subject.keywordGalectin-1
dc.subject.keywordInflammatory bowel disease
dc.subject.keywordImmune regulation
dc.subject.keywordDSS
dc.subject.keywordCell therapy
dc.subject.keywordRegulatory T cells
dc.subject.ucmInmunología
dc.subject.unesco3207.10 Inmunopatología
dc.titleEnhanced susceptibility of galectin-1 deficient mice to experimental colitis
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication
relation.isAuthorOfPublication20129605-5bb5-41f6-8dd8-32c0678ecb2f
relation.isAuthorOfPublication7e782adf-103d-4963-b9cf-ee711e7cb9db
relation.isAuthorOfPublication.latestForDiscovery20129605-5bb5-41f6-8dd8-32c0678ecb2f

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Enhanced_Susceptibility_Galectin-1.pdf
Size:
3 MB
Format:
Adobe Portable Document Format

Collections